Media Room

For More Information Contact

For Media Inquiries:

Dana Korsen
Phone:
202-334-2183
Fax:
202-334-2843
E-mail:
dkorsen@nas.edu

Mailing Address

The National Academies of Sciences, Engineering, and Medicine

Health and Medicine Division

500 Fifth St, NW
Washington, DC 20001

Selected Filters

    • Activity: Scientific Standards for Studies on Modified Risk Tobacco Products [Remove]
    • Topic: Public Health [Remove]

Filter News

News and Announcements

The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.


News Release

Report Specifies Research FDA Should Require Before Allowing ‘Modified Risk’ Tobacco Products to Be Marketed
Released: 12/14/2011

A new Institute of Medicine report specifies the types of research that the Food and Drug Administration should require before allowing tobacco companies to sell or advertise ‘modified risk’ tobacco products as being capable of reducing the health risks of tobacco use. While modified risk tobacco products could be one part of a comprehensive strategy to lower tobacco-related death and disease in the U.S., especially among tobacco users who are unable or unwilling to quit entirely, little is currently known about the products’ health effects and whether they pose less risk than traditional tobacco products. Examples of modified risk tobacco products may include e-cigarettes and tobacco lozenges.

Report at a Glance

Reports: Related Reports
Activities: Related Activities